TikTok Influencers Fueling Parallel Trade for Unapproved Slimming Medication

A shadow market for unapproved weight-loss medications is being driven by TikTok fitness influencers and sellers on messaging platforms, based on recent findings.

Investigational Treatment Acquiring Traction Online

Retatrutide, which remains in clinical trials, is being promoted by social media influencers for its alleged fat-burning properties. Viewers are urged to contact these profiles privately for supplier links, while also obtaining discount codes.

Thriving Trade on Social Networks

Separately, a robust trade exists on Telegram, where groups with thousands of members share “before and after” images, injection guides and claims of next-day British shipping. Sellers promote the drug there before directing customers to other platforms for purchases.

Understanding Retatrutide

Retatrutide is an experimental injection developed by US drugmaker Eli Lilly. The drug affects three gut hormones – GLP-1, GIP and pancreatic hormone. Early trials suggest it could help patients lose up to 25% of their total weight. Referred to as the “triple G”, the drug is being promoted digitally as the successor to Ozempic.

Healthcare Experts Voice Concerns

However, physicians and pharmacists have warned that the distribution of what is still an unlicensed drug in the UK is worrisome and could lead to individuals injecting substances of unknown origin.

Some experts stated the demand for retatrutide could be linked to the rising price of licensed slimming treatments such as Mounjaro.

Legal Position and Enforcement

Marketing retatrutide on social media or messaging apps is prohibited in the United Kingdom, as it is an unapproved drug that cannot be promoted or distributed for human use under the Human Medicines Regulations 2012.

Several influencers attempt to sidestep the rules by calling to the substance as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a controlled drug, but promotion and supply can still breach medicines, advertising, and consumer regulations, potentially leading to fines, prosecution or imprisonment.

Service Reaction and Content Elimination

Based on TikTok, the service has removed violative material and banned associated keywords and search suggestions. The company stated it was dedicated to keeping the platform safe and investing in enhancing compliance measures.

Online Trading Operations

Investigations also found communities with up to 9,000 members selling retatrutide using Telegram's integrated search feature, which operates like a public directory. Typing “retatrutide” immediately brings up channels with numerous of members, populated with images of weight loss, positive reviews and detailed guides for mixing or administering at home.

Within minutes of joining one community, a vendor posted WhatsApp details, where the majority of purchases occur. The seller provided an instruction manual and guaranteed delivery within 48 hours. When asked whether the product was authentic, one vendor responded: “You can’t be sure.” Another provided a image of a supposed laboratory certificate. None inquired about weight, medical conditions or past usage.

Item Details and Pricing

Within these communities, posts show dark colored parcels with postal service stickers, claiming to contain fresh supplies. One message stated: “It took eight of us to load them this morning.”

Buyers can select between powder vials, mixed at residence with purified liquid, or ready-to-use injectors usually sold at 160 pounds for 20mg. When asked how much time a pen should last, sellers give conflicting answers varying between a few weeks to “depends on your body”.

Service Oversight and Safety Actions

A representative for the messaging service stated it actively moderated harmful material on its service including content that encouraged the “misuse of controlled medications”. The company added that it removed “millions of pieces of harmful content each day”.

Healthcare Professional Cautions

“People are injecting substances they can’t verify. Even if the research behind this drug is sound, these online versions may not contain what they claim,” said a pharmacy expert, the head of pharmacy at a pharmacy service.

Dr Crystal Wyllie of an online medical service linked the surge in interest to recent cost increases for approved slimming drugs such as Mounjaro. “With prices increasing, individuals are using online platforms. But counterfeit treatments are extremely dangerous. You can’t be certain what’s contained or whether the environment they were made in was clean,” she explained.

Her team has previously encountered patients harmed by personal administration from unconfirmed sources. “We understand the disappointment, but purchasing from Telegram or WhatsApp is gambling with your health,” stated Wyllie. “These substances could be impure or incorrectly dosed.”

Manufacturer Statement

A spokesperson from the pharmaceutical company stated the substance was in third stage clinical trials and had not been reviewed or approved by any regulatory agency globally. “Consequently at this time no one can sell [it] for personal consumption,” they said, adding that any product “falsely representing itself as a company investigational substance not yet authorized … may subject patients to potentially significant health risks”.